Epigenetics and the IRFs: A complex interplay in the control of immunity and autoimmunity

Autoimmunity

Volumn 47, Issue 4, 2014, Pages 242-255

  Rogatsky, Inez ^a,b   Chandrasekaran, Uma ^b   Manni, Michela ^b   Yi, Woelsung ^b   Pernis, Alessandra B ^a,b,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autoimmunity; Epigenetics; IRF; SLE; Transcription factors

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MICRORNA 122; NUCLEAR RECEPTOR COACTIVATOR; PATTERN RECOGNITION RECEPTOR; PROLACTIN; RNA POLYMERASE II; STAT1 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR NFAT;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; UPREGULATION; ANIMAL; B LYMPHOCYTE; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; EPIGENESIS, GENETIC; HUMANS; IMMUNITY; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES;

EID: 84901066297     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.853050     Document Type: Review

References (210)

1. Eisenberg, R. 2003. Mechanisms of autoimmunity. Immunol. Res. 27: 203-218.
2. Kong, P., J. Odegard, F. Bouzahzah, et al. 2003. Intrinsic T cell defects in systemic autoimmunity. Ann. N Y Acad. Sci. 987: 60-67.
3. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1: 147-153.
4. Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121.
5. Hsu, H. C., P. Yang, J. Wang, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175.
6. Odegard, J. M., B. R. Marks, L. D. Di Placido, et al. 2008. ICOSdependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205: 2873-2886.
7. Vinuesa, C. G., M. C. Cook, C. Angelucci, et al. 2005. A RINGtype ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435: 452-458.
8. Pisitkun, P., H. L. Ha, H. Wang, et al. 2012. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37: 1104-1115.
9. Pernis, A. B. 2009. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J. Intern. Med. 265: 644-652.
10. Crispin, J. C., V. C. Kyttaris, C. Terhorst, et al. 2010. T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6: 317-325.
11. Theofilopoulos, A. N., S. Koundouris, D. H. Kono, et al. 2001. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 3: 136-141.
12. Theofilopoulos, A. N. 2012. TLRs and IFNs: critical pieces of the autoimmunity puzzle. J. Clin. Invest. 122: 3464-3466.
13. Niewold, T. B. 2011. Interferon alpha as a primary pathogenic factor in human lupus. J. Interferon Cytokine Res. 31: 887-892.
14. Crow, M. K. 2010. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. 12: S5.
15. Elkon, K. B., and A. Wiedeman. 2012. Type I IFN system in the development and manifestations of SLE. Curr. Opin. Rheumatol. 24: 499-505.
16. Davidson, A. 2010. Targeting BAFF in autoimmunity. Curr. Opin. Immunol. 22: 732-739.
17. Scapini, P., Y. Hu, C. L. Chu, et al. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773.
18. Schiffer, L., R. Bethunaickan, M. Ramanujam, et al. 2008. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunol. 180: 1938-1947.
19. Lohoff, M., and T. W. Mak. 2005. Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 5: 125-135.
20. Salloum, R., and T. B. Niewold. 2011. Interferon regulatory factors in human lupus pathogenesis. Transl. Res. 157: 326-331.
21. Santana-de Anda, K., D. Gomez-Martin, M. Diaz-Zamudio, et al. 2011. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmun. Rev. 11: 98-103.
22. Tamura, T., H. Yanai, D. Savitsky, et al. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
23. Chen, W., S. S. Lam, H. Srinath, et al. 2008. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 15: 1213-1220.
24. Qin, B. Y., C. Liu, S. S. Lam, et al. 2003. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10: 913-921.
25. Takahasi, K., N. N. Suzuki, M. Horiuchi, et al. 2003. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10: 922-927.
26. Huntzinger, E., and E. Izaurralde. 2011. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12: 99-110.
27. Lee, J. T. 2012. Epigenetic regulation by long noncoding RNAs. Science 338: 1435-1439.
28. Arrowsmith, C. H., C. Bountra, P. V. Fish, et al. 2012. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 11: 384-400.
29. Badeaux, A. I., and Y. Shi. 2013. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14: 211-224.
30. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
31. Natoli, G., S. Ghisletti, and I. Barozzi. 2011. The genomic landscapes of inflammation. Genes Dev. 25: 101-106.
32. Kanno, Y., G. Vahedi, K. Hirahara, et al. 2012. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30: 707-731.
33. Harada, H., T. Fujita, M. Miyamoto, et al. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739.
34. Miyamoto, M., T. Fujita, Y. Kimura, et al. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene regulatory elements. Cell 54: 903-913.
35. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNa and IFNg, and is likely to autoregulate the p91 gene. EMBO J. 13: 158-167.
36. Marsili, G., A. L. Remoli, M. Sgarbanti, et al. 2012. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion. Cytokine Growth Factor Rev. 23: 255-270.
37. Yu-Lee, L. Y., J. A. Hrachovy, A. M. Stevens, et al. 1990. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol. Cell. Biol. 10: 3087-3094.
38. Dogusan, Z., M. L. Book, P. Verdood, et al. 2000. Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells. Eur. Cytokine Netw. 11: 435-442.
39. Coccia, E. M., N. Passini, A. Battistini, et al. 1999. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J. Biol. Chem. 274: 6698-6703.
40. Gupta, S., M. Jiang, and A. B. Pernis. 1999. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J. Immunol. 163: 3834-3841.
41. Gupta, S., D. Xia, M. Jiang, et al. 1998. Signaling pathways mediated by the TNF-and cytokine-receptor families target a common cis-element of the IRF-1 promoter. J. Immunol. 161: 5997-6004.
42. Ohmori, Y., R. Screiber, and T. Hamilton. 1997. Synergy between interferon-g and tumor necrosis factor-a in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kB. J. Biol. Chem. 272: 14899-14907.
43. Pine, R. 1997. Convergence of TNFa and IFNg signaling pathways through synergistic induction of IRF-1/ISGF2 is mediated by a composite GAS/kB promoter element. Nucleic Acids Res. 25: 4346-4354.
44. Klampfer, L., J. Huang, L. A. Swaby, et al. 2004. Requirement of histone deacetylase activity for signaling by STAT1. J. Biol. Chem. 279: 30358-30368.
45. Chang, H. M., M. Paulson, M. Holko, et al. 2004. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl. Acad. Sci. USA 101: 9578-9583.
46. Nusinzon, I., and C. M. Horvath. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. USA 100: 14742-14747.
47. Choi, J. C., R. Holtz, and S. P. Murphy. 2009. Histone deacetylases inhibit IFN-gamma-inducible gene expression in mouse trophoblast cells. J. Immunol. 182: 6307-6315.
48. Su, R. C., A. Sivro, J. Kimani, et al. 2011. Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals. Blood 117: 2649-2657.
49. Buro, L. J., E. Chipumuro, and M. A. Henriksen. 2010. Menin and RNF20 recruitment is associated with dynamic histone modifications that regulate signal transducer and activator of transcription 1 (STAT1)-activated transcription of the interferon regulatory factor 1 gene (IRF1). Epigenetics Chromatin 3: 16.
50. Auriemma, L. B., S. Shah, L. M. Linden, et al. 2012. Knockdown of menin affects pre-mRNA processing and promoter fidelity at the interferon-gamma inducible IRF1 gene. Epigenetics Chromatin 5:2.
51. Shah, S., and M. A. Henriksen. 2011. A novel disrupter of telomere silencing 1-like (DOT1L) interaction is required for signal transducer and activator of transcription 1 (STAT1)-activated gene expression. J. Biol. Chem. 286: 41195-41204.
52. Zhang, R., K. Chen, L. Peng, et al. 2012. Regulation of T helper cell differentiation by interferon regulatory factor family members. Immunol. Res. 54: 169-176.
53. Taki, S., T. Sato, K. Ogasawara, et al. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6: 673-679.
54. Salkowski, C. A., K. Kopydlowski, J. Blanco, et al. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163: 1529-1536.
55. Liu, J., X. Guan, T. Tamura, et al. 2004. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279: 55609-55617.
56. Fantuzzi, G., D. Reed, M. Qi, et al. 2001. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur. J. Immunol. 31: 369-375.
57. Lohoff, M., D. Ferrick, H. Mittrucker, et al. 1997. Interferon regulatory Factor-1 is required for a T helper 1 immune response in vivo. Immunity 6: 681-689.
58. Kano, S., K. Sato, Y. Morishita, et al. 2008. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4\+ T cells. Nat. Immunol. 9: 34-41.
59. Elser, B., M. Lohoff, S. Kock, et al. 2002. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity 17: 703-712.
60. Duncan, G. S., H. W. Mittrucker, D. Kagi, et al. 1996. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184: 2043-2048.
61. Ogasawara, K., S. Hida, N. Azimi, et al. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391: 700-703.
62. Tada, Y., A. Ho, T. Matsuyama, et al. 1997. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 185: 231-238.
63. Reilly, C. M., S. Olgun, D. Goodwin, et al. 2006. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur. J. Immunol. 36: 1296-1308.
64. Pollard, K. M., P. Hultman, C. B. Toomey, et al. 2003. Definition of IFN-gamma-related pathways critical for chemically-induced systemic autoimmunity. J. Autoimmun. 39: 323-331.
65. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
66. Ford, E., and D. Thanos. 2010. The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta 1799: 328-336.
67. Merika, M., A. J. Williams, G. Chen, et al. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1: 277-287.
68. Masumi, A., I. M. Wang, B. Lefebvre, et al. 1999. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol. 19: 1810-1820.
69. Masumi, A., and K. Ozato. 2001. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem. 276: 20973-20980.
70. Masumi, A., H. Fukazawa, T. Shimazu, et al. 2006. Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation. Oncogene 25: 5113-5124.
71. Masumi, A., Y. Yamakawa, H. Fukazawa, et al. 2003. Interferon regulatory factor-2 regulates cell growth through its acetylation. J. Biol. Chem. 278: 25401-25407.
72. Masumi, A. 2011. Histone acetyltransferases as regulators of nonhistone proteins: the role of interferon regulatory factor acetylation on gene transcription. J. Biomed. Biotechnol. 2011: 640610.
73. Zhang, Z., L. Song, K. Maurer, et al. 2010. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun. 11: 124-133.
74. Kim, E. J., J. S. Park, and S. J. Um. 2008. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1. Biochem. Biophys. Res. Commun. 377: 952-956.
75. Park, J., K. Kim, E. J. Lee, et al. 2007. Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis. Proc. Natl. Acad. Sci. USA 104: 17028-17033.
76. Park, S. M., M. Chae, B. K. Kim, et al. 2009. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2. Biochem. Biophys. Res. Commun. 391: 926-930.
77. De Marchis, M. L., M. Ballarino, B. Salvatori, et al. 2009. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 23: 856-862.
78. Lian, J., H. Tian, L. Liu, et al. 2010. Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis. 1: e94.
79. Taylor, K. E., and K. L. Mossman. 2012. Recent advances in understanding viral evasion of type I interferon. Immunology 138: 190-197.
80. Tang, X., J. S. Gao, Y. J. Guan, et al. 2007. Acetylationdependent signal transduction for type I interferon receptor. Cell 131: 93-105.
81. Yoshikawa, T., A. Takata, M. Otsuka, et al. 2012. Silencing of microRNA-122 enhances interferon-alpha signaling in the liver through regulating SOCS3 promoter methylation. Sci. Rep. 2: 637.
82. Liang, D., Y. Gao, X. Lin, et al. 2011. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res. 21: 793-806.
83. Jaspers, I., K. M. Horvath, W. Zhang, et al. 2010. Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza. Am. J. Respir. Cell. Mol. Biol. 43: 368-375.
84. Li, Q., and M. A. Tainsky. 2011. Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses. PLoS ONE 6: e28683.
85. Lu, R., W. C. Au, W. S. Yeow, et al. 2000. Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation. J. Biol. Chem. 275: 31805-31812.
86. Salvi, V., D. Bosisio, S. Mitola, et al. 2010. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. Immunobiology 215: 756-761.
87. Xu, W. D., Y. J. Zhang, K. Xu, et al. 2012. IRF7, a functional factor associates with systemic lupus erythematosus. Cytokine 58: 317-320.
88. Akahoshi, M., H. Nakashima, A. Sadanaga, et al. 2008. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus 17: 568-574.
89. Sanchez, E., M. A. Gonzalez-Gay, J. L. Callejas-Rubio, et al. 2009. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus. Lupus 18: 230-234.
90. Smith, S., J. N. Gabhann, R. Higgs, et al. 2012. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum. 64: 1601-1609.
91. Salloum, R., B. S. Franek, S. N. Kariuki, et al. 2010. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 62: 553-561.
92. Kawasaki, A., H. Furukawa, Y. Kondo, et al. 2012. Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population. Lupus 21: 890-895.
93. Fu, Q., J. Zhao, X. Qian, et al. 2011. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum. 63: 749-754.
94. Sweeney, S. E. 2011. Hematopoietic stem cell transplant for systemic lupus erythematosus: interferon regulatory factor 7 activation correlates with the IFN signature and recurrent disease. Lupus 20: 975-980.
95. Thibault, D. L., A. D. Chu, K. L. Graham, et al. 2008. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 118: 1417-1426.
96. Wathelet, M. G., C. H. Lin, B. S. Parekh, et al. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1: 507-518.
97. Parekh, B. S., and T. Maniatis. 1999. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol. Cell 3: 125-129.
98. Yoneyama, M., W. Suhara, Y. Fukuhara, et al. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095.
99. Kumar, K. P., K. M. McBride, B. K. Weaver, et al. 2000. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20: 4159-4168.
100. Yang, H., C. H. Lin, G. Ma, et al. 2003. Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J. Biol. Chem. 278: 15495-15504.
101. Caillaud, A., A. Prakash, E. Smith, et al. 2002. Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding. J. Biol. Chem. 277: 49417-49421.
102. Flammer, J. R., J. Dobrovolna, M. A. Kennedy, et al. 2010. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol. Cell. Biol. 30: 4564-4574.
103. Reily, M. M., C. Pantoja, X. Hu, et al. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25: 108-117.
104. Nusinzon, I., and C. M. Horvath. 2006. Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Mol. Cell. Biol. 26: 3106-3113.
105. Zhu, J., C. B. Coyne, and S. N. Sarkar. 2011. PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin. EMBO J. 30: 4838-4849.
106. Alam, S., H. Li, A. Margariti, et al. 2011. Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3. J. Biol. Chem. 286: 44211-44217.
107. Genin, P., R. Lin, J. Hiscott, et al. 2012. Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression. PLoS ONE 7: e38336.
108. Icardi, L., S. Lievens, R. Mori, et al. 2012. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J. 26: 240-249.
109. Bentz, G. L., J. Shackelford, and J. S. Pagano. 2012. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J. Virol. 86: 12251-12261.
110. Kubota, T., M. Matsuoka, T. H. Chang, et al. 2008. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 283: 25660-25670.
111. Liang, Q., H. Deng, X. Li, et al. 2011. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J. Immunol. 187: 4754-4763.
112. Liu, G., A. Friggeri, Y. Yang, et al. 2009. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. USA 106: 15819-15824.
113. Gracias, D. T., E. Stelekati, J. L. Hope, et al. 2013. The microRNA miR-155 controls CD8(\+) T cell responses by regulating interferon signaling. Nat. Immunol. 14: 593-602.
114. Biswas, P., G. Bhagat, and A. B. Pernis. 2010. IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol. Rev. 233: 79-96.
115. Nutt, S. L., N. Taubenheim, J. Hasbold, et al. 2011. The genetic network controlling plasma cell differentiation. Semin. Immunol. 23: 341-349.
116. Shaffer, A. L., N. C. Emre, P. B. Romesser, et al. 2009. IRF4: immunity. Malignancy! Therapy? Clin. Cancer Res. 15: 2954-2961.
117. De Silva, N. S., G. Simonetti, N. Heise, et al. 2012. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 247: 73-92.
118. Grossman, A., H. Mittrucker, J. Nicholl, et al. 1996. Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-25. Genomics 37: 229-233.
119. Grumont, R. J., and S. Gerondakis. 2000. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 191: 1281-1292.
120. Matsuyama, T., A. Grossman, H. Mittrucker, et al. 1995. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferonstimulated response element (ISRE). Nucleic Acids Res. 23: 2127-2136.
121. Sharma, S., Y. Mamane, N. Grandvaux, et al. 2000. Activation and regulation of interferon regulatory factor 4 in HTLV type Iinfected lymphocytes. AIDS Res. Hum. Retroviruses 16: 1613-1622.
122. Gupta, S., M. Jiang, A. Anthony, et al. 1999. Lineage-specific modulation of IL-4 signaling by interferon regulatory factor 4. J. Exp. Med. 190: 1837-1848.
123. Chung, Y., S. H. Chang, G. J. Martinez, et al. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
124. Saito, M., J. Gao, K. Basso, et al. 2007. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12: 280-292.
125. Sharma, S., N. Grandvaux, Y. Mamane, et al. 2002. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J. Immunol. 169: 3120-3130.
126. Lehtonen, A., V. Veckman, T. Nikula, et al. 2005. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol. 175: 6570-6579.
127. Zheng, Y., A. Chaudhry, A. Kas, et al. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
128. Brass, A., E. Kehrli, C. Eisenbeis, et al. 1996. Pip, a lymphoidrestricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Develop. 10: 2335-2347.
129. Eisenbeis, C., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Develop. 9: 1377-1387.
130. Satoh, T., O. Takeuchi, A. Vandenbon, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
131. Carreras, E., S. Turner, M. B. Frank, et al. 2010. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115: 238-246.
132. Sebastian, C., M. Serra, A. Yeramian, et al. 2008. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180: 5898-5906.
133. Ortmann, C. A., A. Burchert, K. Holzle, et al. 2005. Downregulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region. Nucleic Acids Res. 33: 6895-6905.
134. Chaudhuri, A. A., A. Y. So, N. Sinha, et al. 2011. MicroRNA-125b potentiates macrophage activation. J. Immunol. 187: 5062-5068.
135. Gururajan, M., C. L. Haga, S. Das, et al. 2010. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int. Immunol. 22: 583-592.
136. Malumbres, R., K. A. Sarosiek, E. Cubedo, et al. 2009. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
137. Brustle, A., S. Heink, M. Huber, et al. 2007. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8: 958-966.
138. Chen, Q., W. Yang, S. Gupta, et al. 2008. IRF-4 Binding Protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 299: 899-911.
139. Honma, K., D. Kimura, N. Tominaga, et al. 2008. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4\+ T cells. Proc. Natl. Acad. Sci. USA 105: 15890-15895.
140. Rengarajan, J., K. A. Mowen, K. D. Mcbride, et al. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195: 1003-1012.
141. Staudt, V., E. Bothur, M. Klein, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
142. Lohoff, M., H.-W. Mittrucker, S. Prechtl, et al. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99: 11808-11812.
143. Bollig, N., A. Brustle, K. Kellner, et al. 2012. Transcription factor IRF4 determines germinal center formation through follicular Thelper cell differentiation. Proc. Natl. Acad. Sci. USA 109: 8664-8669.
144. Kwon, H., D. Thierry-Mieg, J. Thierry-Mieg, et al. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31: 941-952.
145. Huber, M., A. Brustle, K. Reinhard, et al. 2008. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 105: 20846-20851.
146. Cretney, E., A. Xin, W. Shi, et al. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12: 304-311.
147. Klein, U., S. Casola, G. Cattoretti, et al. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
148. Sciammas, R., A. L. Shaffer, J. H. Schatz, et al. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25: 225-236.
149. Shaffer, A. L., N. C. Emre, L. Lamy, et al. 2008. IRF4 addiction in multiple myeloma. Nature 454: 226-231.
150. Yang, Y., A. L. Shaffer 3rd, N. C. Emre, et al. 2012. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell 21: 723-737.
151. Negishi, H., Y. Ohba, H. Yanai, et al. 2005. Negative regulation of toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 102: 15989-15994.
152. Tailor, P., T. Tamura, and K. Ozato. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16: 134-140.
153. Yamamoto, M., T. Kato, C. Hotta, et al. 2011. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS ONE 6: e25812.
154. Lech, M., M. Weidenbusch, O. P. Kulkarni, et al. 2011. IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production. J. Am. Soc. Nephrol. 22: 1443-1452.
155. Biswas, P., S. Gupta, E. Chang, et al. 2010. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120: 3280-3295.
156. Fanzo, J. C., W. Yang, S. Y. Jang, et al. 2006. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J. Clin. Invest. 116: 703-714.
157. Gupta, S., A. Lee, C. Hu, et al. 2003. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Human Immunol. 64: 389-401.
158. Biswas, P. S., S. Gupta, R. A. Stirzaker, et al. 2012. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. J. Exp. Med. 209: 581-596.
159. Lazorchak, A. S., M. S. Schlissel, and Y. Zhuang. 2006. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells. Mol. Cell. Biol. 26: 810-821.
160. Ma, S., A. Turetsky, L. Trinh, et al. 2006. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J. Immunol. 177: 7898-7904.
161. Bevington, S., and J. Boyes. 2012. Transcription-coupled eviction of histones H2A/H2B governs V(D)J recombination. EMBO J 32: 1381-1392.
162. Ciofani, M., A. Madar, C. Galan, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151: 289-303.
163. Cao, Y., H. Li, Y. Sun, et al. 2010. Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression. Eur. J. Immunol. 40: 3198-3209.
164. Cham, C. M., K. Ko, and T. B. Niewold. 2012. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Clin. Dev. Immunol. 2012: 780436.
165. Kozyrev, S. V., and M. E. Alarcon-Riquelme. 2007. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40: 591-601.
166. Shen, H., R. Panchanathan, P. Rajavelu, et al. 2010. Genderdependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J. Mol. Cell. Biol. 2: 284-290.
167. Barnes, B., B. Lubyova, and P. M. Pitha. 2002. On the role of IRF in host defense. J. Interferon Cytokine Res. 22: 59-71.
168. Yamashita, M., M. Toyota, H. Suzuki, et al. 2010. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci. 101: 1708-1716.
169. Balasa, A., G. Gathungu, P. Kisfali, et al. 2010. Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases. Int. J. Colorectal Dis. 25: 553-556.
170. Gestermann, N., M. Koutero, R. Belkhir, et al. 2012. Methylation profile of the promoter region of IRF5 in primary Sjogren's syndrome. Eur. Cytokine Netw. 23: 166-172.
171. Polioudakis, D., A. A. Bhinge, P. J. Killion, et al. 2013. A MycmicroRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes. Nucleic Acids Res. 41: 2239-2254.
172. Tang, Y., X. Luo, H. Cui, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075.
173. Takaoka, A., H. Yanai, S. Kondo, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
174. Krausgruber, T., K. Blazek, T. Smallie, et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12: 231-238.
175. Paun, A., R. Bankoti, T. Joshi, et al. 2011. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7: e1001246.
176. Fang, C. M., S. Roy, E. Nielsen, et al. 2012. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun. 13: 421-430.
177. Lien, C., C. M. Fang, D. Huso, et al. 2010. Critical role of IRF-5 in regulation of B-cell differentiation. Proc. Natl. Acad. Sci. USA 107: 4664-4668.
178. Savitsky, D. A., H. Yanai, T. Tamura, et al. 2010. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl. Acad. Sci. USA 107: 10154-10159.
179. Purtha, W. E., M. Swiecki, M. Colonna, et al. 2012. Spontaneous mutation of the Dock2 gene in Irf5-/-mice complicates interpretation of type I interferon production and antibody responses. Proc. Natl. Acad. Sci. USA 109: E898-E904.
180. Feng, D., L. Yang, X. Bi, et al. 2012. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur. J. Immunol. 42: 1477-1487.
181. Tada, Y., S. Kondo, S. Aoki, et al. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum. 63: 738-748.
182. Xu, Y., P. Y. Lee, Y. Li, et al. 2012. Pleiotropic IFN-dependent and-independent effects of IRF5 on the pathogenesis of experimental lupus. J. Immunol. 188: 4113-4121.
183. Yang, L., D. Feng, X. Bi, et al. 2012. Monocytes from Irf5-/-mice have an intrinsic defect in their response to pristane-induced lupus. J. Immunol. 189: 3741-3750.
184. Richez, C., K. Yasuda, R. G. Bonegio, et al. 2010. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/-mouse models of systemic lupus erythematosus. J. Immunol. 184: 796-806.
185. Feng, D., N. Sangster-Guity, R. Stone, et al. 2010. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J. Immunol. 185: 6003-6012.
186. Eames, H. L., D. G. Saliba, T. Krausgruber, et al. 2012. KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages. Immunobiology 217: 1315-1324.
187. Wang, H., and H. C. Morse 3rd. 2009. IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol. Res. 43: 109-117.
188. Cattoretti, G., R. Shaknovich, P. M. Smith, et al. 2006. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 177: 6930-6939.
189. Banik, D., A. N. Khan, E. Walseng, et al. 2012. Interferon regulatory factor-8 is important for histone deacetylase inhibitormediated antitumor activity. PLoS ONE 7: e45422.
190. Lee, K. Y., H. Geng, K. M. Ng, et al. 2008. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene 27: 5267-5276.
191. McGough, J. M., D. Yang, S. Huang, et al. 2008. DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol. Cancer Res. 6: 1841-1851.
192. Yang, D., M. Thangaraju, K. Greeneltch, et al. 2007. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res. 67: 3301-3309.
193. Basso, K., C. Schneider, Q. Shen, et al. 2012. BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. J. Exp. Med. 209: 2455-2465.
194. Li, H. S., N. Greeley, N. Sugimoto, et al. 2012. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS ONE 7: e52341.
195. Marquis, J. F., O. Kapoustina, D. Langlais, et al. 2011. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet. 7: e1002097.
196. Dror, N., M. Alter-Koltunoff, A. Azriel, et al. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol. Immunol. 44: 338-346.
197. Satpathy, A. T., K. M. Murphy, and W. Kc. 2011. Transcription factor networks in dendritic cell development. Semin. Immunol. 23: 388-397.
198. Tailor, P., T. Tamura, H. J. Kong, et al. 2007. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27: 228-239.
199. Kim, Y. M., H. S. Kang, S. G. Paik, et al. 1999. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J. Immunol. 163: 2000-2007.
200. Ouyang, X., R. Zhang, J. Yang, et al. 2011. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat. Commun. 2: 314.
201. Wang, I. M., C. Contursi, A. Masumi, et al. 2000. An IFN-gammainducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165: 271-279.
202. Lu, R., K. L. Medina, D. W. Lancki, et al. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17: 1703-1708.
203. Shin, D. M., C. H. Lee, and H. C. Morse 3rd. 2011. IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS ONE 6: e27384.
204. Cunninghame Graham, D. S., D. L. Morris, T. R. Bhangale, et al. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7: e1002341.
205. Lessard, C. J., I. Adrianto, J. A. Ice, et al. 2012. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90: 648-660.
206. Baccala, R., R. Gonzalez-Quintial, A. L. Blasius, et al. 2013. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl. Acad. Sci. USA 110: 2940-2945.
207. Yuan, W., S. Gupta, X. Hu et al. 2013. Rho-kinases modulate the ability of interferon regulatory factor 8 to regulate BAFF production in Murine Macrophages. Submitted.
208. Kuwata, T., C. Gongora, Y. Kanno, et al. 2002. Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element. Mol. Cell. Biol. 22: 7439-7448.
209. Huang, W., W. Zhou, G. Saberwal, et al. 2010. Interferon consensus sequence binding protein (ICSBP) decreases betacatenin activity in myeloid cells by repressing GAS2 transcription. Mol. Cell. Biol. 30: 4575-4594.
210. Fragale, A., E. Stellacci, R. Ilari, et al. 2011. Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells. J. Immunol. 186: 1951-1962.